MedPath

Evaluation of effect of magnesium sulfate on reduction of cerebral vasospasm?

Phase 2
Conditions
Cerebral aneurism ?.
Subarachnoid haemorrhage from intracranial artery, unspecified
Registration Number
IRCT2013042813159N1
Lead Sponsor
Vice Chancellor for Research, Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
46
Inclusion Criteria

The major inclusion criteria?:?
candidate for brain aneurysm surgery after 3 days of aneurysm bleeding;?
American Society of Anesthesiologists (ASA) class I and II.?
The major exclusion criteria:?
pathology of cardiovascular system; heart failure [Ejection fraction (EF) less than ??40%].
Previous history of hypertension; Liver or kidney diseases (impaired Liver function ?test (FT) and Glomerular filtration rate (GFR) less than 50 ml/min); Motor, ?neurological, and muscle disorders, coagulopathy [Prothrombin time (PT) more than ??16, International Normalized Ratio (INR) more than 1.5; Partial thromboplastin ?time (PTT) more than 35]; Hypomagnesaemia, More than 60 years of age;? History of allergy to any of the used medications in the experiment,?
? Overweight [Body mass index (BMI) more than 30]; Previous use of calcium channel ?blockers; Atrioventricular block.?

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Vasospasm. Timepoint: After intervention, daily. Method of measurement: Angiography and transcranial Doppler.;Mean arterial pressure. Timepoint: Before infusion, 5 minutes after infusion, every 15 minutes after infusion. Method of measurement: Arterial Line during the surgery.;Heart rate. Timepoint: Before infusion, 5 minutes after infusion, every 15 minutes after infusion. Method of measurement: Heart monitoring during the surgery.
Secondary Outcome Measures
NameTimeMethod
Bleeding rate. Timepoint: End of surgery. Method of measurement: Based on CC of gases and suction contents.;The amount of anesthetic drugs used (propofol 2 mg/kg, fentanyl 2 mcg/kg, atracurium 0.5 mg/kg lidocaine 1.5 mg/kg). Timepoint: End of surgery. Method of measurement: Based on patient weight (kg) and Duration of Surgery.
© Copyright 2025. All Rights Reserved by MedPath